Harvard Bioscience
HBIO
HBIO
81 hedge funds and large institutions have $72.1M invested in Harvard Bioscience in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
12% less capital invested
Capital invested by funds: $82.2M → $72.1M (-$10.2M)
Holders
81
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$680K | |
| 2 | +$342K | |
| 3 | +$334K | |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$164K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$156K |
Top Sellers
| 1 | -$380K | |
| 2 | -$294K | |
| 3 | -$216K | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$122K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$121K |